共 167 条
[11]
Jung KW(2007)Changes in spinal and supraspinal endocannabinoid levels in neuropathic rats Neuropharmacology 52 1381-1354
[12]
Cho S(2018)Scaffold hopping-guided design of some isatin based rigid analogs as fatty acid amide hydrolase inhibitors: synthesis and evaluation Biomed Pharmacother 107 2612-813
[13]
Lee DH(2004)Monoglyceride lipase-like enzymatic activity is responsible for hydrolysis of 2-arachidonoylglycerol in rat cerebellar membranes Biochem Pharmacol 67 1340-2103
[14]
Lau BK(2016)Development and pharmacological characterization of selective blockers of 2-arachidonoyl glycerol degradation with efficacy in rodent models of multiple sclerosis and pain J Med Chem 59 799-159
[15]
Vaughan CW(2018)Discovery of 1, 5-diphenylpyrazole-3-carboxamide derivatives as potent, reversible, and selective monoacylglycerol lipase (MAGL) inhibitors J Med Chem 61 2090-1049
[16]
Jhaveri MD(2015)Genetic deletion of monoacylglycerol lipase leads to impaired cannabinoid receptor CB 1R signaling and anxiety-like behavior J Neurochem 135 153-120
[17]
Richardson D(2018)Development of potent inhibitors of fatty acid amide hydrolase useful for the treatment of neuropathic pain ChemMedChem 13 1039-87
[18]
Chapman V(2014)The dual FAAH/MAGL inhibitor JZL195 has enhanced effects on endocannabinoid transmission and motor behavior in rats as compared to those of the MAGL inhibitor JZL184 Pharmacol Biochem Behav 124 111-813
[19]
Jaiswal S(2013)Dual inhibition of endocannabinoid catabolic enzymes produces enhanced antiwithdrawal effects in morphine-dependent mice Neuropsychopharmacology 38 77-784
[20]
Uniyal A(2015)Full fatty acid amide hydrolase inhibition combined with partial monoacylglycerol lipase inhibition: augmented and sustained anti-nociceptive effects with reduced cannabimimetic side effects in mice J Pharmacol Exp Ther 354 801-323